by Andreu Prados
Chronic constipation affects around one in ten adults worldwide. The new British Dietetic Association’s guidelines suggest shifting from generic high-fiber diets to specific foods and drinks to improve constipation.
by Andreu Prados
Chronic constipation affects around one in ten adults worldwide. The new British Dietetic Association’s guidelines show that psyllium, certain probiotic strains and magnesium oxide supplements can help to improve constipation.
Emerging studies suggest the gut microbiome may predict how well you age. The world’s oldest person offers scientists new clues into the secrets of healthy aging and protection against the diseases that often plague the final years of life.
by Andreu Prados
Cardiovascular diseases remain one of the most pressing public health concerns, demanding innovative research to identify novel causes. A recent Nature study reported that imidazole propionate made by gut bacteria contributes to atherosclerosis development, supporting its potential role as a biomarker of subclinical disease.
by Andreu Prados
Although the underlying cause of irritable bowel syndrome is unclear, many people with IBS believe they are sensitive to gluten or wheat. A new study finds gluten and wheat are safe for many people with IBS, and the culprit might be something else.
The 6th biennial meeting of the European Society of Neurogastroenterology and Motility, held at Queen Mary University of London, UK, from 4-6 September 2025, covered basic, translational, and clinical research in neurogastroenterology, including dietary therapies and ‘biotics’ for the management of gastrointestinal disorders. Find out more about the main takeaways from the conference.
by Andreu Prados
Many patients with IBS find that wheat or gluten triggers gastrointestinal symptoms, prompting them to exclude these foods from their diets. A new study highlights how patients’ expectations and beliefs shape symptom modulation and dietary choices in IBS.
Digestive Disease Week 2025 featured recent basic, translational, and clinical research into the microbiome. Find out more about the main takeaways relevant for your clinical practice selected by GMFH editors.
Prebiotics have been widely researched in the context of gastrointestinal conditions and might hold potential to influence cognition outcomes by modulating the microbiota-gut-brain axis. A new randomised controlled trial in individuals aged over 60s showed that a prebiotic blend (inulin and fructo-oligosaccharides) is well tolerated and may improve cognition compared with a placebo.
Microbes living in your digestive tract may help you achieve or maintain a healthy body weight by influencing your food intake behaviors. This article delves into what scientists know and do not know about gut microbiota and obesity and provides science-backed tools for leveraging the microbes in your gut to achieve a healthier body weight.
